Skip Navigation

Cardiovascular Research 2004 63(1):1-4; doi:10.1016/j.cardiores.2004.04.028
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tritto, I.
Right arrow Articles by Ambrosio, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tritto, I.
Right arrow Articles by Ambrosio, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

The multi-faceted behavior of nitric oxide in vascular "inflammation": catchy terminology or true phenomenon?

Isabella Tritto and Giuseppe Ambrosio*

Division of Cardiology, University of Perugia School of Medicine, Ospedale Silvestrini, via S. Andrea delle Fratte, 06156 Perugia, Italy

*Corresponding author. Tel.: +39-75-527-1509; fax: +39-75-527-1244. Email address: giuseppe.ambrosio@ospedale.perugia.it

Received 19 April 2004; accepted 23 April 2004

Abbreviations: NO, nitric oxide • OFRs, oxygen free radicals • ONOO, peroxynitrite • VSMCs, vascular smooth muscle cells • O2, superoxide radical

The first 10% of the full text of this article appears below.

See article by Hattori et al. [11] (pages 31–40) in this issue.

Over the last 20 years, our understanding of the role of nitric oxide (NO) in biological systems has evolved enormously. Once considered merely a vasodilator (albeit a very powerful one), NO has subsequently attracted attention for its ability to modulate a number of intracellular pathways at the vascular and extravascular level. This is, however, when the headache began. The flurry of studies investigating a variety of possible cellular targets soon led to the discovery that, under different conditions, several pathophysiological events could be affected by NO by seemingly divergent mechanisms.

Initial studies pointed towards a protective effect of NO on cellular activities, indicating that NO would prevent development of the pro-atherogenic phenotype in endothelial cells and vascular smooth muscle cells, reduce leukocyte adhesion and recruitment . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
X. Liu, Y. Huang, P. Pokreisz, P. Vermeersch, G. Marsboom, M. Swinnen, E. Verbeken, J. Santos, M. Pellens, H. Gillijns, et al.
Nitric Oxide Inhalation Improves Microvascular Flow and Decreases Infarction Size After Myocardial Ischemia and Reperfusion
J. Am. Coll. Cardiol., August 21, 2007; 50(8): 808 - 817.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. Andreadou, E. K. Iliodromitis, E. Mikros, M. Constantinou, A. Agalias, P. Magiatis, A. L. Skaltsounis, E. Kamber, A. Tsantili-Kakoulidou, and D. T. Kremastinos
The Olive Constituent Oleuropein Exhibits Anti-Ischemic, Antioxidative, and Hypolipidemic Effects in Anesthetized Rabbits
J. Nutr., August 1, 2006; 136(8): 2213 - 2219.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. K. Biswas and J. B. Lopes de Faria
Does peroxynitrite sustain nuclear factor-{kappa}B?
Cardiovasc Res, September 1, 2005; 67(4): 745 - 746.
[Full Text] [PDF]